Juan C. Nieto
@jcnietos.bsky.social
PhD. Immunologist in the Single-Cell Genomics Team at the CNAG in Barcelona. Focus on the application and interpretation of Single-Cell Genomics studying inflammation, autoimmune disorders, oncology and immunotherapy.
Reposted by Juan C. Nieto
🌍 Meet Dr @jcnietos.bsky.social, immunologist at #CNAG, at #IUIS2025!
🗣️ He’ll give an oral abstract presentation on “Interpretable Inflammation Landscape of Circulating Immune Cells”
📌 @iuis-online.bsky.social (Vienna, Austria)
🗓️ Thursday, August 21 | 10:30 – 12:00
ℹ️ iuis2025.org
🗣️ He’ll give an oral abstract presentation on “Interpretable Inflammation Landscape of Circulating Immune Cells”
📌 @iuis-online.bsky.social (Vienna, Austria)
🗓️ Thursday, August 21 | 10:30 – 12:00
ℹ️ iuis2025.org
August 20, 2025 at 7:41 AM
🌍 Meet Dr @jcnietos.bsky.social, immunologist at #CNAG, at #IUIS2025!
🗣️ He’ll give an oral abstract presentation on “Interpretable Inflammation Landscape of Circulating Immune Cells”
📌 @iuis-online.bsky.social (Vienna, Austria)
🗓️ Thursday, August 21 | 10:30 – 12:00
ℹ️ iuis2025.org
🗣️ He’ll give an oral abstract presentation on “Interpretable Inflammation Landscape of Circulating Immune Cells”
📌 @iuis-online.bsky.social (Vienna, Austria)
🗓️ Thursday, August 21 | 10:30 – 12:00
ℹ️ iuis2025.org
Reposted by Juan C. Nieto
🔬An aggressive #ChildhoodCancer case opens new avenues for advanced cell therapies.
✍️ #IRBBarcelona, @cnag-eu.bsky.social, @sjdhospitalbarcelona.org
📰 Annals of Oncology
Read more here ➡️ bit.ly/40Ut5lC
📌 DOI: 10.1016/j.annonc.2025.05.530
#IRBScience
🧪
✍️ #IRBBarcelona, @cnag-eu.bsky.social, @sjdhospitalbarcelona.org
📰 Annals of Oncology
Read more here ➡️ bit.ly/40Ut5lC
📌 DOI: 10.1016/j.annonc.2025.05.530
#IRBScience
🧪
July 16, 2025 at 8:47 AM
🔬An aggressive #ChildhoodCancer case opens new avenues for advanced cell therapies.
✍️ #IRBBarcelona, @cnag-eu.bsky.social, @sjdhospitalbarcelona.org
📰 Annals of Oncology
Read more here ➡️ bit.ly/40Ut5lC
📌 DOI: 10.1016/j.annonc.2025.05.530
#IRBScience
🧪
✍️ #IRBBarcelona, @cnag-eu.bsky.social, @sjdhospitalbarcelona.org
📰 Annals of Oncology
Read more here ➡️ bit.ly/40Ut5lC
📌 DOI: 10.1016/j.annonc.2025.05.530
#IRBScience
🧪
Reposted by Juan C. Nieto
Don't miss this chance to engage with the experts as they present single-cell research for complex diseases. Learn how this technology is being used to uncover new insights into type 2 diabetes, brain tumors, and leptomeningeal disease.
Register here: www.workcast.com/register?cpa...
Register here: www.workcast.com/register?cpa...
February 28, 2025 at 1:56 PM
Don't miss this chance to engage with the experts as they present single-cell research for complex diseases. Learn how this technology is being used to uncover new insights into type 2 diabetes, brain tumors, and leptomeningeal disease.
Register here: www.workcast.com/register?cpa...
Register here: www.workcast.com/register?cpa...
Big thanks to @paulanietog.bsky.social , @piazeiner.bsky.social , @hoheyn.bsky.social & the team for this collaboration! 🚀 Our study shows how CSF liquid biopsy mirrors CNS tumor immunity using single-cell & spatial transcriptomics. Insights into T cell responses, myeloid dominance & biomarkers!
📢 SUPER EXCITED to share our latest preprint:
Decoding the immune response in leptomeningeal disease through single-cell sequencing of cerebrospinal fluid
Incredible work and collaboration from @jcnietos.bsky.social @piazeiner.bsky.social @hoheyn.bsky.social and others.
biorxiv.org/content/10.110…
Decoding the immune response in leptomeningeal disease through single-cell sequencing of cerebrospinal fluid
Incredible work and collaboration from @jcnietos.bsky.social @piazeiner.bsky.social @hoheyn.bsky.social and others.
biorxiv.org/content/10.110…
https://biorxiv.org/content/10.110…
January 29, 2025 at 2:11 PM
Big thanks to @paulanietog.bsky.social , @piazeiner.bsky.social , @hoheyn.bsky.social & the team for this collaboration! 🚀 Our study shows how CSF liquid biopsy mirrors CNS tumor immunity using single-cell & spatial transcriptomics. Insights into T cell responses, myeloid dominance & biomarkers!